ArticleBioinformatics (Oxford, England)2025
FACT: Feature Aggregation and Convolution with Transformers for predicting drug classification code.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Multimodal Sequence-to-Sequence Model for Automatic Assignment of ATC Codes in Drug Discovery and Repurposing.Journal of chemical information and modeling · 2026Article
- TriDTI: tri-modal representation learning with cross-modal alignment for drug-target interaction prediction.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
motivationDrug repositioning, identifying new therapeutic applications for existing drugs, can significantly reduce the time and cost involved in drug development. Recent studies have explored the use of Anatomical Therapeutic Chemical (ATC) codes in drug repositioning, offering a systematic framework to predict ATC codes for a drug. The ATC classification system organizes drugs according to their chemical properties, pharmacological actions, and therapeutic effects. However, its complex hierarchical structure and the limited scalability at higher levels present significant challenges for achieving accurate ATC code prediction.
resultsWe propose a novel approach to predict ATC codes of drugs, named Feature Aggregation and Convolution with Transformer models (FACT). This method computes three types of drug similarities, incorporating ATC code similarity with hierarchical weights and masked drug-ATC code associations. These features are then aggregated for each target drug-ATC code pair and processed through a convolution-transformer encoder to generate three embeddings. The embeddings are finally used to estimate the probability of an association between the target pair. The experimental results demonstrate that the proposed method achieves an area under the receiver operating characteristic curve (AUROC) of 0.9805 and an area under the precision-recall curve of 0.9770 at level 4 of the ATC codes, outperforming the previous methods by 15.05% and 18.42%, respectively. This study highlights the effectiveness of integrating diverse drug features and the potential of transformer-based models in ATC code prediction. AVAILABILITY AND IMPLEMENTATION: Source code of FACT is freely available at https://github.com/knhc1234/FACT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.